| NOTCH2 — Notch Receptor 2 | |
|---|---|
| Symbol | NOTCH2 |
| Full Name | Notch Receptor 2 |
| Chromosome | 1p11 |
| NCBI Gene | 4853 |
| Ensembl | ENSG00000134250 |
| OMIM | 600275 |
| UniProt | Q12983 |
| Diseases | Alzheimer's Disease, CADASIL, Hajdu-Cheney Syndrome |
| Expression | Cerebral cortex, Hippocampus, Vascular smooth muscle |
Notch2 — Notch Receptor 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NOTCH2 encodes a member of the Notch family of receptors, which are highly conserved transmembrane proteins essential for cell fate determination, development, and tissue homeostasis. Notch2 plays critical roles in neurogenesis, angiogenesis, and immune cell development.
Notch2 is a transmembrane receptor that undergoes proteolytic cleavage upon ligand binding (Jagged or Delta-like ligands). Key functions include:
Notch2 interacts with amyloid precursor protein (APP) processing and may influence amyloid-beta production. Changes in Notch2 signaling are observed in AD brains:
NOTCH2 mutations cause Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a hereditary small vessel disease leading to stroke and dementia.
Notch2 signaling modulators are being explored for:
The study of Notch2 — Notch Receptor 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.